Status
Conditions
About
Prospective observational study recruiting elderly patients of 60 years and above admitted to Intensive Care Unit (ICU), to study multiple domains of biomarkers ability to predict mortality of patients during intensive care unit admission and functional disability in survivors after ICU discharge
Full description
Study Design This is a prospective observational study to develop & validate a prognostic predictive model to predict ICU mortality (primary outcome) using Multi-Biomarkers concept. The study design for Predictive Modelling Study (Prognostic) will be "Type 2a: Nonrandom split-sample development and validation" study design according to "Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis".
3.2 Study Sites
3.3 Study Duration Part of the study already ongoing in General ICU, Hospital Universiti Sains Malaysia and Intensive Care Unit SASMEC. Study duration will start in both Hospital Queen Elizabeth and Hospital Queen Elizabeth II when approval from MREC is obtained. Study duration expected for 2 years, estimated to complete in the end of 2023. Tentatively, it will start on 1st of June 2022 till 31st December 2022.
3.4 Target Population: Inclusion & Exclusion Criteria 3.4.1 Inclusion Criteria
3.6 Sampling Method Sampling method that will be employed is consecutive sampling, starting from the set period of study duration (earliest patient record in the database) until completion of 329 patients enrolled
3.7 Outcome Measures
Primary Outcome
Secondary Outcome
3.8 Data Collection 3.8.1 Data Collection Form Data will be collected and collected into a de-identified physical CRF 3.8.2 Data to be collected All the necessary demographic data as well as previous variables found to be significant in previous studies looking into prognostic factors of the elderly. Multi-biomarker investigations will be performed on the patients upon admission. In addition, as much data as possible that was collected from the database will be entered into the prognostic modeling to improve the robustness of the prognostic model.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
329 participants in 2 patient groups
Loading...
Central trial contact
Abdul Jabbar Ismail, MBBS; Wan Fadzlina Wan Shukeri, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal